GN Store Nord A/S
OTC:GGNDF
GN Store Nord A/S
OTC:GGNDF
Price:
14.13
USD
Market Closed
Market Cap:
$2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
GN Store Nord A/S
OTC:GGNDF
|
DK |
|
M
|
Marks and Spencer Group PLC
SWB:MA6
|
UK |
|
Sweco AB (publ)
STO:SWEC B
|
SE |
|
Osirium Technologies PLC
LSE:OSI
|
UK |
|
K
|
Kyowa Leather Cloth Co Ltd
TSE:3553
|
JP |
|
Rajnish Wellness Ltd
BSE:541601
|
IN |
|
A
|
Akanda Corp
NASDAQ:AKAN
|
UK |
|
IQE PLC
LSE:IQE
|
UK |
|
V
|
Vicem Energy and Environment JSC
VN:VTV
|
VN |
|
S
|
SBW Life Sciences Co Ltd
KOSDAQ:151910
|
KR |
|
Wow World Inc
TSE:2352
|
JP |
|
N
|
Noble Helium Ltd
ASX:NHE
|
AU |
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
TW |
Multiples-Based Value
The Multiples-Based Value of one
GGNDF
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 14.13 USD,
GN Store Nord A/S
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GGNDF Multiples-Based Value
LOCKED
Multiples Across Competitors
GGNDF Competitors Multiples
GN Store Nord A/S Competitors
GN Store Nord A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
GN Store Nord A/S
OTC:GGNDF
|
14.3B USD | 0.9 | 22.7 | 7.5 | 13.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.4B USD | 4 | 27 | 15.5 | 21.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.3B USD | 16.5 | 58.2 | 44.1 | 54.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130.5B USD | 5.2 | 40.2 | 20.5 | 24.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.8B USD | 4.8 | 33.1 | 19.6 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.2B EUR | 1.9 | 20.5 | 11.4 | 16.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.3B USD | 10.8 | 43.7 | 30.9 | 34.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.5 | 42.3 | 23 | 25.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.5B USD | 1.6 | 16.1 | 11.5 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
